Navigation Links
SENOMYX ANNOUNCES FIRST QUARTER 2009 FINANCIAL RESULTS
Date:5/7/2009

Recent Accomplishments Include:

- Decision by Nestle SA to select a new flavor ingredient for evaluation of commercial potential in the coffee and coffee whitener fields

- Extension of discovery and development program with Ajinomoto Co., Inc.

- Extension of collaborative research and license agreement with Campbell Soup Company

- Initiation of development activities to support regulatory filings for Bitter Blockers S0812 and S6821

SAN DIEGO, CA, May 7, 2009 /PRNewswire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX), a company focused on using proprietary taste receptor-based technologies to discover novel flavor ingredients for the food, beverage, and ingredient supply industries, today reported financial results for the first quarter ended March 31, 2009. As of March 31, 2009, the Company had approximately $33 million in cash, cash equivalents, and investments available-for-sale and no debt.

"Senomyx started 2009 with the extension of our collaborative agreements with Ajinomoto and Campbell, as well as notable progress in our Discovery & Development programs," said Kent Snyder, President and Chief Executive Officer of the Company. "We are gratified that our ongoing scientific advances have led to continued support from our world-class partners.

"Most recently, Nestle, the world's largest food and beverage company and a partner for several of Senomyx's Discovery & Development programs, selected a new flavor ingredient discovered by Senomyx for advancement into the development phase. Selection occurs when a partner determines that a new flavor ingredient has met their requirements for initiation of development activities and evaluation of commercial potential," Snyder stated. "The ingredient selected by Nestle is intended to be used in the
'/>"/>

SOURCE Senomyx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. SENOMYX ANNOUNCES NESTLES SELECTION OF A NEW FLAVOR INGREDIENT FOR EVALUATION OF COMMERCIAL POTENTIAL
2. SENOMYX, INC. FIRST QUARTER 2009 EARNINGS CONFERENCE CALL SCHEDULED FOR MAY 7, 2009
3. SENOMYX ANNOUNCES EXTENSION OF ITS COLLABORATION WITH CAMPBELL SOUP COMPANY
4. SENOMYX ANNOUNCES THE EXTENSION OF ITS COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT WITH AJINOMOTO CO., INC.
5. SENOMYX ANNOUNCES FOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS
6. SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW BITTER BLOCKERS
7. SENOMYX, INC. fourth quarter AND FISCAL YEAR-END 2008 Earnings conference call scheduled for February 12, 2009
8. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 11TH ANNUAL NEEDHAM GROWTH STOCK CONFERENCE
9. SENOMYX AND FIRMENICH TO COLLABORATE ON COMMERCIALIZATION OF S2383, A NOVEL ENHANCER OF THE HIGH-INTENSITY SWEETENER SUCRALOSE
10. SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS
11. SENOMYX ANNOUNCES RECEIPT OF MILESTONE PAYMENT FROM THE COCA-COLA COMPANY
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 2014 CASI Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapeutics addressing cancer and ... a primary commercial focus on China ... Type C meeting with the U.S. Food and Drug ... in February 2015.  During this meeting the Company will ...
(Date:12/15/2014)... METTLER TOLEDO is pleased to announce that the ... PVM technology , is now available. The new ... continuously captures high-resolution images under a wide range ... a report pairing the most relevant images to ... compelling blend of high resolution images and trend ...
(Date:12/15/2014)... Dec. 15, 2014  GlassesOff Inc. (OTCBB: GLSO) announced ... as an independent director of the Company,s Board of ... and served as its CEO until its acquisition by ... $240 million transaction. Recognized as the inventor of the ... AeroScout provided Wi-Fi -based RFID solutions focused on improving ...
(Date:12/13/2014)... CHARLOTTE, N.C. (PRWEB) December 13, 2014 ... (UNC Charlotte) spin-out company has changed its name to ... more accurate representation of where we are today,” said ... “We’ve extended our platform’s applications beyond breast cancer diagnostics ... is a reflection of that evolution.” , Founded in ...
Breaking Biology Technology:CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO 2AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3CanDiag Inc. Expands Product Scope Under a New Name: OncoTab, Inc. 2
... Pharmaceuticals,Inc. (Nasdaq: ANDS ) announced today that it ... Healthcare Conference on Monday, May 19, 2008 at,10:00 a.m. ... Beach Plaza,Hotel in Monte Carlo, Monaco. Steve Worland, Ph.D., ... overview of Anadys and an,update on its two development-stage ...
... Investments,Inc. (AMEX: MGT ), a technology holding ... today reported financial results,for the first quarter ended ... milestones., Tim Paterson-Brown, MGT Chairman and CEO, ... point for our subsidiaries, Medicsight and,Medicexchange. In the ...
... - Adds significant strategic biotech business experience -, ... Corporation,(Nasdaq: VRNM ), a pioneer in the ... today announced the,appointment of John F. Dee to ... Geoffrey Hazlewood, Ph.D., Senior Vice President of,Research, has ...
Cached Biology Technology:Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences 2MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments 2MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments 3MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments 4Verenium Appoints John F. Dee to Board of Directors 2Verenium Appoints John F. Dee to Board of Directors 3Verenium Appoints John F. Dee to Board of Directors 4Verenium Appoints John F. Dee to Board of Directors 5
(Date:12/17/2014)... 15, 2014 The Defense Logistics Agency ... to detect and prevent counterfeit microcircuits from entering ... agency started performing an in-house microcircuit anti-counterfeit initiative ... authenticity of purchased microcircuits while increasing their reliability ... measures will be conducted at DLA,s Electronics Product ...
(Date:12/17/2014)... , Dec. 16, 2014  Automation is ... this more evident than at international borders. Over ... document scanners have allowed veteran travelers to self ... Passport Control (APC) Kiosks at an increasing number ... globe. According to Maxine ...
(Date:12/11/2014)... WINSTON SALEM, N.C. , Dec. 10, 2014  That ... known for quite a while. Hypertension – the medical term ... disease in the early 1800s, and the inflatable cuff that,s ... That doesn,t, however, mean there,s nothing new about hypertension, ... punctured some long-held beliefs about the condition and the best ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... Fla. (April 19, 2010) A unique cell type ... (olfactory system) known as olfactory ensheathing cells (OECs), possess ... and have become prime candidates for transplantation to repair ... (CNS). Transplanted OECs, known to retain exceptional plasticity and ...
... new, dissolvable nicotine pellet--which is being sold as a ... candies--could lead to accidental nicotine poisoning in children, according ... Public Health (HSPH), the Northern Ohio Poison Control Center, ... the Food and Drug Administration (FDA). The researchers also ...
... out Nature,s purpose behind an astonishing variety of tiny ocean ... ticket-holder in life,s lottery, awaiting conditions that will allow it ... of the hardest-to-see sea species -- tiny microbes, zooplankton, larvae ... all other life on Earth -- is the focus of ...
Cached Biology News:Cell transplants may benefit children with cerebral palsy 2Tobacco company's new, dissolvable nicotine products could lead to accidental poisoning 2Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 2Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 3Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 4Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 5Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 6Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 7Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 8Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 9Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 10
Streptomycin sulfate an aminoglycoside used for bacterial selection binds to the small ribosomal subunit and interferes with protein biosynthesis.21H39N7O12)2x3H2SO4Formula weight:...
...
The BD OptEIA Rat TNF-alpha ELISA Kit is for the quantitative determination of TNF-alpha in rat serum, plasma and cell culture supernatant....
Geneticin Selective Antibiotic liquid...
Biology Products: